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Persistent pain induced by noxious stimuli is charac-
terized by the transition from normosensitivity
to hypersensitivity. Underlying mechanisms are not
well understood, although gene expression is con-
sidered important. Here, we show that persistent
nociceptive-like activity triggers calcium transients
in neuronal nuclei within the superficial spinal dorsal
horn, and that nuclear calcium is necessary for
the development of long-term inflammatory hyper-
sensitivity. Using a nucleus-specific calcium signal
perturbation strategy in vivo complemented by
gene profiling, bioinformatics, and functional anal-
yses, we discovered a pain-associated, nuclear
calcium-regulated gene program in spinal excitatory
neurons. This includes C1q, a modulator of synaptic
spine morphogenesis, which we found to contribute
to activity-dependent spine remodelling on spinal
neurons in a manner functionally associated with
inflammatory hypersensitivity. Thus, nuclear cal-
cium integrates synapse-to-nucleus communication
following noxious stimulation and controls a spinal
genomic response that mediates the transition be-
tween acute and long-term nociceptive sensitization
by modulating functional and structural plasticity.
INTRODUCTION
Peripheral and central neural networks mediating the complex
experience of pain show various forms of plasticity in patholog-
ical disease states over diverse temporal and anatomical scales
that lead to exaggerated responses to noxious stimuli (hyperal-
gesia), and may contribute to aberrant pain sensation in re-
sponse to nonnoxious sensory inputs (allodynia) (Kuner, 2010;Sandku¨hler, 2009). Despite recent advances, the molecular
basis of transitions between acute sensitization and long-term
hypersensitivity is not well understood. Tremendous potential
for long-term plasticity lies in the ability of synaptic nociceptive
mediators and cellular modulators to trigger changes in gene
expression (Woolf and Costigan, 1999). Addressing how local
synaptic events are spatiotemporally linked to the modulation
of gene expression in pain networks is therefore important for
understanding sensitization mechanisms.
Recent studies have revealed important insights into routes for
synapse-to-nucleus communication in the context of neuronal
survival and long-term memory (Hagenston and Bading, 2011).
Calcium signals couple synaptic activity to the regulation of
gene transcription, and thus serve as mediators of the dialog
between synapses and the nucleus (Hardingham et al., 2001;
Bengtson et al., 2010). Nuclear calcium acting primarily via
nuclear calcium/calmodulin-dependent (CaM) protein kinases II
and IV regulates genomic programs, which have been studied
in the context of neuronal survival, synaptic plasticity, and
memory formation, particularly in hippocampal neurons (Lim-
ba¨ck-Stokin et al., 2004; Zhang et al., 2007, 2009; Mauceri
et al., 2011; Oliveira et al., 2012). The cyclic AMP response
element binding protein (CREB), a major target of nuclear
calcium-CaMKIV signaling (Hardingham et al., 1997, 2001), can
bind to and influence the activity of 4,000 to 6,000 promoter sites
in the rat or human genomes (Impey et al., 2004). Nuclear
calcium-CaMKIV signaling also regulates the activity of the tran-
scriptional coactivator CREB binding protein (CBP) (Hagenston
and Bading, 2011), which interacts with CREB but also with a
number of other DNA binding proteins (Vo and Goodman,
2001). Furthermore, nuclear calcium also initiates genome-wide
modifications of the chromatin state in response to synaptic
activity; e.g., via CaMKII-mediated phosphorylation of methyl-
CpG-binding protein 2 (MeCP2) on its activator site serine
421 (Buchthal et al., 2012), or transcriptional induction of the
de novo DNA methyltransferase, Dnmt3a2 (Oliveira et al., 2012).
Previous studies have reported roles for many transcriptional
regulators including CREB and MeCP2 in nociceptive plasticityNeuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc. 43
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Nuclear Calcium Signaling in Pain(Fang et al., 2002; Ji et al., 1999; Ge´ranton et al., 2007). However,
little is known about the potential for nociceptive activity to
trigger nuclear calcium signaling, and it remains unknown
whether nuclear calcium serves as a signaling end point in
pain-associated synapse-to-nucleus communication.
Here, we show that persistent nociceptive-like activity triggers
calcium transients in the nuclei of spinal dorsal horn neurons,
which play a key role in the development of persistent inflam-
matory pain, but not in the basal pain sensitivity or the acute
sensitization evoked by nociceptive inputs. A genome-wide
transcriptome analysis uncovered a distinct spinal gene pool
directly regulated by nuclear calcium that includes not only
a large set of known, key pain-related genes, but also plas-
ticity-related genes and regulators of spinal dendritic spine
remodeling. Thus, functional and structural plasticity governed
by a nuclear calcium-driven genomic response is a key inter-
mediate step linking nociceptive activity and the development
of long-lasting hypersensitivity.
RESULTS
Viral-Mediated Delivery of Tools for Analyzing Nuclear
Calcium Signaling in the Mouse Spinal Cord In Vivo
We used recombinant adeno-associated virus (rAAV)-mediated
gene delivery (During et al., 2003) to overexpress molecular tools
for either imaging or quenching nuclear calcium signals. Our
objective was to specifically target excitatory neurons in the
superficial spinal laminae that receive and process nociceptive
information from peripheral sensory afferents and then subse-
quently project this information to the brain. Nuclear calcium
signaling was blocked by means of expression of calmodulin
binding protein 4 (CaMBP4), a nuclear protein that contains
four repeats of the M13 calmodulin-binding peptide derived
from the rabbit skeletal muscle myosin light chain kinase, which
has been characterized previously (Wang et al., 1995; Zhang
et al., 2007, 2009; Mauceri et al., 2011). CaMBP4 does not buffer
calcium, but instead binds calcium-bound calmodulin and
prevents the activation of downstream signaling cascades. Its
effects on synaptic activity-dependent transcription that are
associated with acquired neuroprotection and memory forma-
tion have been characterized previously both in vitro and in vivo
(Mauceri et al., 2011; Limba¨ck-Stokin et al., 2004; Zhang et al.,
2007, 2009). The rAAV vectors used contain an expression
cassette that harbors a promoter fragment derived from the
CaMKIIa promoter and drives expression of mCherry (rAAV-
mCherry) or mCherry fused to either CaMBP4 (rAAV-CaMBP4)
(Figure 1A) or to the inactive CaMBP4 mutant, CaMBP4mu
(rAAV-CaMBP4mu). To preferentially infect neurons, the neuro-
tropic chimeric serotype 1/2 was used (During et al., 2003).
We have previously demonstrated that stereotaxic injection of
rAAVs (serotype 1/2) directly into the spinal parenchyma enables
stable and long-lasting gene delivery with a high rate of gene
transduction without inducing any signs of persistent inflamma-
tion, injury, gliosis, or scar formation (Tappe-Theodor et al.,
2007). By mapping the cellular expression patterns of
mCherry-tagged CaMBP4 (CaMBP4-mCherry) and mCherry as
the prototypes for the different virally expressed proteins used
in this study, we found that viral-mediated expression was44 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.largely limited to the spinal dorsal horn and, owing to the incor-
poration of a nuclear localization signal in the expression
constructs, was restricted to cell nuclei (Figure S1A available
online).
Coimmunostaining for the neuronal marker NeuN demon-
strated a more than 90% colocalization with mCherry or
mCherry-tagged CaMBP4 in the superficial spinal laminae
(Figures 1B and S1B; quantification in Figure 1C), but not with
GFAP, an astrocytic marker, or with Iba1, a microglial marker
(Figures 1B and S1B). Using indicator mice that express
enhanced green fluorescent protein (EGFP) in the cell bodies
of either glycinergic inhibitory neurons (GlyT2-EGFP) or
GABAergic inhibitory interneurons (GAD67-EGFP), we observed
that only a small proportion (6%–7%) of inhibitory glycinergic or
GABAergic interneurons expressed CaMBP4 or mCherry in the
spinal dorsal horn (typical examples in Figure 1D; quantitative
analysis in Figure 1E). Expression in the spinal dorsal horn was
evident throughout the spinal segments L2–S1, but reached its
maximum in L3–L5, which innervate the hindpaw (Figure S1C).
Nociceptive-like Synaptic Activity Induces Calcium
Transients in Neuronal Nuclei of the Spinal Dorsal Horn
Although it has been suggested that synaptic activity-induced
calcium signals can be transduced to the cell soma and invade
the cell nucleus, for example in hippocampal neurons (Hardi-
ngham et al., 2001), only recently has it become possible to
unambiguously detect calcium transients in the nuclear
compartment using genetically encoded calcium indicators tar-
geted specifically to cell nuclei (Bengtson et al., 2010). We
used rAAVs to express the calcium sensors GCaMP2.NLS
(Bengtson et al., 2010) or TnXXL.NLS, which are targeted to
the nucleus via a tripartite nuclear localization signal at their C
termini, in excitatory neurons of the L3–L5 lumbar spinal cord
(Figure 1F). In acute transverse slices from mice injected with
rAAV-GCaMP2.NLS (Figure S2A), electrical stimulation of dorsal
roots through a suction electrode (20–100 Hz, 0.4–2.0 mA)
induced fluorescence intensity changes (Figure 1G), which cor-
responded with nuclear calcium transients having a steep rise
and slower decay, and which returned to near-baseline values
within 10 s of stimulus conclusion (traces in Figure 1H). The
amplitudes of evoked nuclear calcium transients varied posi-
tively with both stimulus intensity (0.4–2.0 mA) (Figures 1I and
1J) and frequency (20–100 Hz) (for example, transients at 0.8
mA stimulation intensity are shown in Figure 1K). These data indi-
cate that robust nuclear calcium responses in nociceptive spinal
neurons can be evoked through repetitive stimulation—an
activity pattern that may accompany a persistent nociceptive
stimulus following injury—as well as by the recruitment of noci-
ceptive C-fiber afferents, which occurs predominantly at higher
stimulation intensities (Torsney and MacDermott, 2006).
Similar results were obtained when we employed a nuclearly
targeted FRET-based calcium indicator, TnXXL.NLS, which, by
virtue of being a ratiometric, is expected to deliver more consis-
tent responses across experimental preparations independently
of expression levels. The amplitudes of evoked nuclear calcium
transients (Figure S2D) varied positively with both stimulus inten-
sity (Figures S2E and S2F) and frequency (Figure S2G). When
imaging was performed 24 hr after bilateral plantar injection of
Figure 1. Viral Vector-Mediated Gene
Transfer to the Lumbar Spinal Dorsal Horn
In Vivo
(A) Schematic representation of two rAAVs: a nu-
clearly targeted mCherry control (mCherry.NLS)
and a nuclear-localized,mCherry-taggedCaMBP4
(CaMBP4).
(B) Coexpression of CaMBP4 with neuronal
(NeuN), astrocytic (GFAP), and microglial (Iba-1)
marker proteins in the spinal dorsal horn (scale
bar, 50 mm).
(C) Quantification of mCherry.NLS and CaMBP4
colocalization with NeuN in the spinal cord dorsal
horn (L3–L5).
(D and E) Typical expression patterns of
CaMBP4 and EGFP in glycinergic (GlyT2-EGFP)
or GABAergic (GAD67-EGFP) indicator mice
(scale bar, 100 mm in D) and quantification of
colocalization (E).
(F and G) rAAV expressing genetically encoded
nuclear calcium indicator, GCaMP2.NLS, and
nuclear calcium signals observed in dorsal horn
neurons prior to (pre) and upon electrical stimu-
lation of the ipsilateral dorsal root (post).
(H) Typical DF/F trace of nuclear calcium tran-
sients evoked by 1 s, 100 Hz stimulation of the
dorsal root.
(I and J) Summary of data showing the relative
amplitudes of nuclear calcium signals evoked by
1 s dorsal root stimulation of varying amplitudes
at 20 Hz (n = up to 24 slices) (I) or 100 Hz (n = up to
18 slices) (J).
(K) Summary data showing the relative amplitudes
of nuclear calcium signals evoked by 1 s, 0.8 mA
stimulus trains of varying frequency (n = up to 10
slices).
All data are expressed as mean ± SEM. See also
Figures S1 and S2.
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Nuclear Calcium Signaling in Paincomplete Freund’s adjuvant (CFA) or PBS (control), we found
no detectable differences in the amplitudes of nuclear calcium
transients in spinal neurons between CFA-treated and PBS-
treated animals, regardless of the stimulation intensity (0.2–3.0
mA) or frequency (1–100 Hz) used (Figures S2E–S2G).
Impact of the Blockade of Nuclear Calcium Signaling
on Behavioral Correlates of Nociception
and Inflammatory Pain
Using a dynamic aesthesiometer to measure mechanical
sensitivity and a plantar test device to study responses to sensi-Neuron 77, 43–tivity to infrared heat, we observed that
basal pain sensitivity was similar in mice
expressing CaMBP4-mCherry (hereafter
referred to simply as CaMBP4) or
mCherry (control) in the spinal dorsal
horn (Figures 2A and 2B). CaMBP4
expression did, however, significantly
impair the development of mechanical
and thermal hypersensitivity following
the induction of unilateral hindpaw inflam-
mation with CFA. Following CFA-inducedinflammation, mCherry-expressing mice showed markedly
reduced response latencies to thermal stimulation compared
to baseline (black circles in Figure 2C; p < 0.05, ANOVA). This
thermal hypersensitivity lasted for up to 7 days following CFA
injection. In contrast, CFA-induced inflammation did not sig-
nificantly alter thermal latency in rAAV-CaMBP4-injected
animals (red squares in Figure 2C). Similarly, the development
of mechanical hypersensitivity, evident as a decrease in the
mechanical response threshold over baseline, occurred promi-
nently in rAAV-mCherry-injected mice, but only to a minor extent
in rAAV-CaMBP4-injected animals (Figure 2D) throughout the57, January 9, 2013 ª2013 Elsevier Inc. 45
Figure 2. Inhibitors of Nuclear Calcium
Signaling in the Spinal Dorsal Horn Disrupt
the Development of Inflammatory Hyperal-
gesia but Do Not Influence Basal Pain
Sensitivity
(A and B) Animals expressing mCherry (control,
black symbols), functional CaMBP4 (red symbols),
or an inactive mutant of CaMBP4 (CaMBP4mu,
green symbols) were subjected to punctuate
mechanical pressure stimuli (dynamic aesthesi-
ometer in A) or radiant heat (plantar test with heat
ramp in B).
(C and D) Drop in paw withdrawal latency (C) or
mechanical response thresholds (D) over time
following CFA-induced unilateral hindpaw inflam-
mation on day 0 (*p < 0.05 relative to baseline;
yp < 0.05 relative to mCherry; one-way ANOVA,
post hoc Dunnett’s test).
(E) Integrals of mechanical stimulus-response
frequency curves for von Frey hair forces ranging
from 0.07 to 2 g following unilateral hindpaw CFA
injection (yp < 0.05 relative to mCherry).
(F) Anti-Flag immunohistochemistry showing
localization of dominant-negative CaMKIV
(CaMKIVK75E) in the spinal dorsal horn (scale =
100 mm; higher magnification in panel at the
right, scale = 50 mm).
(G and H) CFA-induced mechanical hyper-
sensitivity in control mice and mice expressing
CaMKIVK75E expressed as percent change over
baseline (G) or as integral of the entire von Frey
stimulus intensity-response frequency curve (H)
(*p < 0.05 relative to baseline; yp < 0.05 relative to
mCherry; one-way ANOVA followed by Dunnett’s
test).
(I) CFA-induced thermal hypersensitivity in control
mice and in mice expressing CaMKIVK75E (one-
way ANOVA).
In all panels, n = 8–10 mice per treatment group.
All data are expressed as mean ± SEM. See also
Figures S1 and S3.
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Nuclear Calcium Signaling in Paintime course of CFA-induced inflammation (up to 10 days; p <
0.05, ANOVA). In these experiments, graded von Frey hairs
(0.07–4 g) were applied to the plantar surface and withdrawal
threshold was determined as the von Frey filament at which
the animal withdrew its paw at least three times out of eight
applications, normalizing basal (pre-CFA) values to 100%. The
drop in withdrawal threshold was significantly less pronounced
in mice expressing CaMBP4 as compared to mice expressing
mCherry (Figure 2D). To comprehensively present all data on
response frequencies to graded von Frey hairs over all forces
tested, we constructed a response frequency versus stimulus
intensity (i.e., von Frey force applied) curve per group for
every time point tested and calculated area under curve (AUC),
which was markedly lower in CaMBP4-expressing mice than in
mCherry-expressing mice (Figure 2E). Importantly, mice ex-
pressing an inactive mutant of CaMBP4 (CaMBP4mu) exhibited46 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.normal levels of thermal and mechanical
hyperalgesia (Figure 2C-E), indicating
that the altered nociceptive sensitivity inCaMBP4-expressing mice can be attributed to the functional
properties of CaMBP4.
Role of a Nuclear Calcium Effector, CaMKIV, in Spinal
Nociceptive Sensitization
Among the various signaling events triggered by nuclear
calcium/calmodulin, CaMKIV is particularly important for gene
regulation (Kotera et al., 2005; Racioppi and Means, 2008). To
address whether CaMKIV signaling contributes to the observed
phenotypic profile of nuclear calcium signaling manipulation,
we used a kinase-dead, dominant-negative mutant version of
CaMKIV, CaMKIVK75E (Mauceri et al., 2011; Zhang et al., 2009).
Following rAAV-mediated spinal expression of a FLAG-tagged
version of CaMKIVK75E, anti-FLAG immunoreactivity revealed
the typical, primarily cytosolic localization of CaMKIVK75E
(Chow et al., 2005) over the entire neuronal soma and the
Figure 3. Contribution of Nuclear Calcium
Signaling in Spinal Dorsal Horn Neurons to
Phosphorylation of CREB and ERK1/2 and
Temporal Analysis of the Course of Gene
following CFA-Induced Unilateral Hindpaw
Inflammation
(A and B) Typical examples of immunoreactivity
for pCREB (A) or western blotting of pCREB and
its densitometric quantification upon normalizing
total CREB levels (B) in the spinal dorsal horn at
24 hr after CFA injection as compared to basal
state in mice spinally expressing mCherry or
CaMBP4.
(C and D) Typical examples of immunoreactivity
for phosphorylated ERK1 and ERK2 (pERK1/2) in
the spinal dorsal horn (C) or western blotting of
pERK1 and pERK2 and densitometric quantifi-
cation upon normalizing total ERK1 or ERK2 levels
(D) at 24 hr after CFA injection over basal values
in mice spinally expressing mCherry or CaMBP4
(*p < 0.05 compared to basal levels). Scale bars,
100 mm.
(E and F) Quantitative RT-PCR analysis of time
course of upregulation of typical immediate-
early genes (E) and genes encoding some typical
effectors of nociceptive hypersensitivity (F) in
spinal dorsal horn of wild-type mice following
CFA-induced paw inflammation (n = at least 3
each).
In all panels, ANOVA was performed followed by
post hoc Fisher’s test (*p < 0.05 compared to basal
levels (0 hr); yp < 0.05 compared to the mCherry
group). In (A–D), n = 4–5 mice per treatment group.
All data are expressed as mean ± SEM. See also
Figure S1.
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Nuclear Calcium Signaling in Painneuropil of superficial spinal dorsal horn neurons (Figure 2F;
higher magnification in right-hand panel). Following CFA-
induced paw inflammation, mice injected into the spinal cord
with rAAV-CaMKIVK75E initially developed mechanical hyper-
sensitivity to a similar extent as rAAV-mCherry-injected mice
(Figures 2G and 2H), but significantly less mechanical hyper-
sensitivity than the mCherry-expressing group starting 3 days
after injection and, unlike rAAV-mCherry-injected mice, recov-
ered baseline mechanical sensitivity within 5 days after injection
(Figures 2G and 2H). In contrast, CFA-induced thermal hyper-
sensitivity was not markedly affected in rAAV-CaMKIV75E-
injected mice (Figure 2I), indicating that particularly the late
phase of nuclear calcium-induced mechanical hypersensitivity,
but not thermal hypersensitivity, is mediated by activation of
CaMKIV in excitatory neurons of the spinal dorsal horn.Neuron 77, 43–Interference with Nuclear Calcium
Signaling Abrogates Nociceptive
Activity-Dependent Activation of
CREB Despite Intact ERK1/2
Activation
At 24 hr following CFA-induced peripheral
inflammation, the serine 133-phospho-
rylated form of CREB (pCREB) showed
increased immunoreactivity in the somataover the entire spinal dorsal horn in rAAV-mCherry-injected
animals (Figure 3A), as well as increased expression in immuno-
blot analyses using lysates of bilaterally isolated spinal dorsal
horns following bilateral intraplantar injection of CFA (Figure 3B;
quantitative analysis fromat least three experiments in Figure 3B,
right panel). In contrast, in mice expressing CaMBP4, paw
inflammation failed to increase pCREB immunoreactivity and
pCREB expression levels in the spinal dorsal horn (Figures 3A–
3B) without any change in basal levels of pCREB immuno-
reactivity or expression levels of CREB protein in the spinal
cord (Figures 3A–3B).
In contrast, after CFA-induced paw inflammation, increased
immunoreactivity for the activated (i.e., phosphorylated) forms
of ERK1 and ERK2 (pERK1/2) was observed in the neuropil of
the superficial spinal dorsal horn in rAAV-mCherry-injected57, January 9, 2013 ª2013 Elsevier Inc. 47
Figure 4. Effects of CaMBP4-Induced Dis-
ruption of Spinal Nuclear Calcium Signaling
on Behavioral Manifestations of Early Noci-
ceptive Hypersensitivity and Persistent
Inflammatory Pain
Mice represented in (A–D) received AAV1/2-
mediated spinal delivery of CaMBP4 (red symbols)
or mCherry (black symbols) 4 weeks prior to being
tested in the capsaicin or arthritis models. Mice
represented in (E) and (F) received viral-mediated
spinal delivery of CaMBP4 or mCherry at 36 hr
after induction of knee arthritis.
(A and B) The cumulative durations of acute noci-
fensive behaviors evoked by intraplantar injection
of capsaicin (A) or formalin (B) are shown (p > 0.05;
Student’s t test).
(C and D) Mechanical hypersensitivity following
knee arthritis is represented as a change in
mechanical threshold over baseline in percentage
in (C) and as an integral of the entire von Frey
stimulus intensity-response frequency curve over
time after knee arthritis in (D).
In all of the above panels, n = 8–10 mice/treatment
group.
(E and F) Effects of spinal expression of mCherry
(n = 8) or CaMBP4 (n = 8) using rAAVs injected
2 days after induction of knee arthritis. Mechanical
hypersensitivity is represented as an integral of
the entire von Frey stimulus intensity-response
frequency curve over time after knee arthritis in (E).
Mechanical sensitivity of the same cohort of mice
to a low-intensity von Frey stimulus of 0.07 g is
shown in (F).
In (C–F): *p < 0.05 as compared to baseline values;
yp < 0.05 as compared to the mCherry group;
ANOVA followed by post hoc Dunnett’s test. All
data are expressed as mean ± SEM. See also
Figures S1 and S3.
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Nuclear Calcium Signaling in Painmice as well as in rAAV-CaMBP4-injected mice (Figure 3C),
which was further confirmed by immunoblot analysis (Figure 3D).
These results indicate an absence of compensatory changes in
parallel modes of synapse-to-nucleus communication following
specific perturbation of nuclear calcium signaling in the spinal
dorsal horn.
Upon induction of paw inflammation, immediate-early genes
(IEGs) such as c-fos and egr1, as well as critical effector genes
of nuclear calcium signaling such as camk2a and ptgs2 (encod-
ing Cox-2), were found to undergo a biphasic transcriptional
response with a rapid and transient induction within the first 1
to 6 hr after stimulation, followed by a delayed increase in
expression at 24 hr (Figures 3E and 3F), which matched the
functional outcomes (i.e., behavioral hypersensitivity and
structural plasticity) that we analyzed 24 hr after induction of
nociceptive activity (see below).48 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.Differential Regulation of Acute or
Chronic Plasticity Processes
Regulated by Nuclear Calcium
Signals in the Spinal Cord
Wenext investigated the temporal phases
over which nuclear calcium-driven plas-ticity processes are operational. We observed that intraplantar
injection of capsaicin in the paw acutely evoked nocifensive
behaviors, which range over tens of seconds to a few minutes,
to a similar extent in rAAV-CaMBP4-injected and rAAV-
mCherry-injected mice (Figure 4A). Furthermore, intraplantar
formalin-induced acute nociceptive behaviors (phase 1, 0–
10 min postinjection) and the development of acute nociceptive
hypersensitivity, which is known to depend on plasticity in the
central nervous system as well as on-going nociceptor activa-
tion (phase 2, 15–60 min), were comparable between rAAV-
CaMBP4-injected and rAAV-mCherry-injected mice (Figure 4B).
The mouse knee arthritis model, which involves unilateral
knee-injection of kaolin and carrageenan, enables the assess-
ment of secondary hyperalgesia at hindpaws ipsilateral and
contralateral to the inflamed knee (i.e., distinct dermatomes
and contralateral processing), and thereby provides insight
Neuron
Nuclear Calcium Signaling in Paininto central (spinal) mechanisms of nociceptive plasticity span-
ning several weeks. Whereas rAAV-mCherry-injected mice
showed ipsilateral hypersensitivity beginning within a few days
and lasting several weeks after induction of knee arthritis,
rAAV-CaMBP4-injected mice failed to develop hyperalgesia
over the entire temporal course of arthritic pain assessment
(Figures 4C and 4D). Similar results were obtained for the con-
tralateral paw hyperalgesia after knee arthritis (Figures S3A
and S3B). These behavioral differences did not result from
variations in the magnitude of inflammation, since knee edema
as well as infiltration of GR1-immunoreactive macrophages
into the synovial membrane (Gangadharan et al., 2011) were
comparable in rAAV-mCherry-injected and rAAV-CaMBP4-
injectedmice (Figures S3C and S3D). Taken together, the results
obtained from the capsaicin, formalin, paw inflammation, and
knee arthritis models suggest that nuclear signaling-dependent
plasticity processes do not become evident until several hours
after intense nociceptive activity, and that they can persist for
several weeks.
Phase-Dependent Blockade of Inflammatory Pain
by Spinal CaMBP4
To determine the contribution of nuclear calcium signaling to
the maintenance of inflammatory hypersensitivity independently
of the induction phase, we induced arthritic pain prior to ex-
pression of CaMBP4. Following development of mechanical
hypersensitivity 36 hr after arthritis induction (Figure 4E), mice
were randomly divided into two groups receiving spinal injec-
tion of rAAV-mCherry or rAAV-CaMBP4. In a pilot experiment,
we ascertained that injecting rAAVs in the spinal dorsal horn
did not, by itself, affect arthritic hypersensitivity at 2 or 3 days
after surgery. Corresponding to the time course of viral ex-
pression (i.e., starting at 7 days), rAAV-CaMBP4-injected mice
showed significantly less mechanical hypersensitivity than did
rAAV-mCherry-injected mice starting from day 15 onward after
injection (p < 0.05, ANOVA) (summary of sensitivity over all
mechanical forces is shown in Figure 4E and responses to a
force of 0.07 g shown in Figure 4F). Despite this difference,
CaMBP4-expressing mice exhibited levels of mechanical sensi-
tivity that were significantly greater than baseline, with a temporal
course similar to that observed in rAAV-mCherry-injected mice
(Figures 4E and 4F); the partial reduction is likely attributed to
spinal plasticity downstream of ongoing afferent input coming
in from the arthritic knee. These results suggest that spinal
nuclear calcium signaling plays a more decisive role in the
induction phase than it does in the maintenance phase of
nociceptive hypersensitivity.
Profiling Genes Regulated by Nuclear Calcium Signaling
in Spinal Neurons during Inflammatory Pain
A genome-wide gene profiling in the CFA model of inflam-
matory pain was used to identify genes regulated by persistent
nociceptive activity in spinal neurons, and to identify the
gene pool that is specifically regulated by nuclear calcium
signaling. cDNA prepared from spinal dorsal horn tissue 24 hr
after bilateral intraplantar paw injection of CFA (inflamed)
in rAAV-mCherry or rAAV-CaMBP4-injected mice was used
for microarray-based transcriptome analysis, and the degreeof induction or repression over basal state (control) was
analyzed.
We found 3,165 genes to be upregulated and 5,143 genes to
be downregulated with a p value % 0.050 in inflamed versus
control samples derived from rAAV-mCherry-injected mice
(t tests with Benjamini-Hochberg correction for multiple com-
parisons). To narrow down the gene pool for subsequent
detailed analyses, we set a cut-off of 1.40-fold for upregulated
genes and of 0.70-fold for downregulated genes in mCherry-
expressing mice and assessed how CaMBP4 expression influ-
enced the inflammation-induced upregulation or downregulation
of each of these selected genes (Figures 5A–5D). All genes
regulated in nuclear calcium-dependent manner by the criteria
used (see Experimental Procedures) are listed in Table S1. The
complete profiling data is shown in Table S2. Individual upregu-
lated or downregulated genes are schematically represented
at the same position in Figures 5A–5D. Of the 202 genes upregu-
lated at least 1.40-fold following CFA injection in mCherry-
expressing mice, 127 genes (i.e., 63%) were not induced by
CFA by at least 1.40-fold in CaMBP4-expressing mice (Table
S1); these genes were categorized as ‘‘100% inhibition of
induction byCaMBP4’’ (see Experimental Procedures for details)
and marked as dark blue fields in Figure 5B (detailed information
on percent difference in fold induction is provided in Table S2).
The induction of 26 genes was inhibited by at least 20% and
that of many more genes was inhibited by between 10% and
20% (indicated by fields in graded shades of blue in Figure 5B).
Of the 288 genes repressed by CFA by at least 0.70-fold in
mCherry-expressing mice, 164 genes (i.e., 57%) were not
repressed by at least 0.70-fold by peripheral inflammation in
CaMBP4-expressing mice (Table S1); they were categorized
as ‘‘100% inhibition of repression by CaMBP4’’ (see Experi-
mental Procedures for details) and marked as dark blue fields
in Figure 6D (detailed information on percent difference in fold
repression is provided in Table S2). The downregulation of
another 34 genes was inhibited by at least 20% (blue shaded
fields in Figure 5D) (Table S1). A small number of genes that
was repressed or induced by paw inflammation in rAAV-
mCherry-injected mice was found to be repressed or induced
to a greater extent in rAAV-CaMBP4-injected mice (6.6% and
5%, respectively), suggesting that nuclear calcium signaling
serves to counteract an endogenous mechanism involved in
the repression of these genes by paw inflammation (yellow-
and brown-shaded fields Figure 5D) (Table S1). About 28%
of all genes regulated within the above-mentioned cutoff in
a nuclear calcium-dependent manner in the spinal dorsal horn
represent known or putative targets of CREB as predicted by
the CREB Target Gene Database (Salk Institute). Importantly,
we also observed that the regulation of a subset of genes by
paw inflammation was not significantly affected by the blockade
of nuclear calcium signaling: about 10% of genes upregulated
by at least 1.40-fold and 19% of genes downregulated by at
least 0.70-fold in mCherry-expressing mice exhibited similar
levels of regulation by paw inflammation in CaMBP4-expressing
mice (white fields in Figures 5B and 5D, respectively).
The validity of the transcriptome data was confirmed by
quantitative reverse transcriptase-polymerase chain reaction
(QRT-PCR) analysis; one example, grip1, a gene encoding theNeuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc. 49
Figure 5. Representation of Gene Profiling
Data Derived from Spinal Dorsal Horns of
CaMBP4-ExpressingMice andmCherry-Ex-
pressing Mice in the Basal State or 24 hr
after CFA-Mediated Bilateral Paw Inflam-
mation
(A–D) Representation of genes upregulated with
a cutoff of 1.40 (A) or downregulated with a cutoff
of 0.70 (C) in CFA-inflamedmice over basal state in
mCherry mice. Changes in CFA-induced upregu-
lation (B) or downregulation (D) of individual
genes by spinal expression of CaMBP4 are rep-
resented, segregated according to magnitude of
modulation (color key on the extreme right; white
fields represent CFA-regulated genes that are not
affected by CaMBP4 expression). Each field in (A)
and (C) represents one gene, and the same gene
is represented in corresponding fields in the (B)
and (D), respectively. See Experimental Proce-
dures for a detailed description of the method
used to calculate percent modulation of CFA-
induced gene regulation by CaMBP4.
(E) Validation of genes regulated in profiling
experiments via QRT-PCR on cDNA derived from
spinal dorsal horns of mice in the basal state and
24 hr after CFA-induced paw inflammation.
(F) Attenuation of CFA-induced upregulation of
ptgs2 gene encoding Cox-2 in the spinal dorsal
horn of mice expressing an shRNA against ptgs2
in the spinal cord (Student’s t test).
(G andH) Comparison of CFA-inducedmechanical
hypersensitivity (G) or thermal hyperalgesia (H) in
mice spinally expressing shRNA against Ptgs2 or
control RNA (H) (n = 8–10 mice per treatment
group; *p < 0.05 compared to baseline values;
ANOVA followed by post hoc Dunnett’s test).
All data are expressed as mean ± SEM (n = 4
per group). See also Figure S4 and Tables S1
and S2.
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Nuclear Calcium Signaling in Painkey postsynaptic protein GRIP1 at excitatory synapses (Dong
et al., 1997), is shown in Figure 5E. As expected from previous
profiling analyses (e.g., Zhang et al., 2007, 2009), the level of
regulation determined by QRT-PCR analysis was much higher
than that observed in the gene chip-based assessment.
Whereas CaMBP4 expression suppressed gene expression of
some genes in both basal and inflammatory states (e.g., the
genes encoding Tachykinin1 [tac1] and Cholecystokinin [cck]
[Figure 5E]), expression of others was only suppressed in in-
flamed mice (e.g., gucy1a2, which encodes soluble guanylate
cyclase 1 [Figure 5E]).
Nuclear Calcium Mediates Activity-Induced Regulation
of a Large Set of Pain-Relevant Genes
Among the genes that were significantly regulated by paw
inflammation (p < 0.05) in a nuclear calcium-dependent manner
using the criteria mentioned above, we found a large number
of genes encoding proteins that have been implicated in the50 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.positive or negative modulation of noci-
ception. We chose Cox-2 (ptgs2) as an
example of a prominent pain target(Vardeh et al., 2009), and found that its regulation by nuclear
calcium signaling occurs both in the spinal dorsal horn (Figure 5F)
and, as shown previously (Zhang et al., 2009), in hippocampal
neurons. Mice spinally injected with rAAVs to express a Cox-2
specific short hairpin RNA (shRNA) showed lower levels of
Cox-2-induction 24 hr after paw inflammation than mice ex-
pressing a control shRNA (Figure 5F), although due to expression
of Cox-2 in glial cells (Vardeh et al., 2009) that are not targeted
by the rAAV, significant amounts of Cox-2 mRNA could still be
detected in the spinal cord. The selective knockdown of Cox-2
expression in spinal excitatory neurons resulted in a failure of
the animals to develop mechanical hypersensitivity following
paw inflammation (Figure 5G), but no change in CFA-induced
thermal hypersensitivity was observed (Figure 5H).
Interestingly, our profiling results indicate marked differences
in gene programs associated with inflammatory and neuropathic
pain states. For example, genes encoding P2X4, MMP-2, and
cathepsin S, which are upregulated in neuropathic pain states
Figure 6. Analysis of the Regulation of
Nuclear Calcium-Gene Targets in Models
of Peripheral Inflammation or Neuropathy
and Phenotypic Characterization of the
Influence of Blockade of Spinal Nuclear
Calcium Signaling on Neuropathic Pain
(A and B) Quantitative RT-PCR analysis of spinal
expression of some neuropathic pain-associated
genes at 24 hr post-CFA (A) and of some inflam-
matory pain-associated genes 7 days after SNI (B)
(n = 3 mice per condition in A and B).
(C and D) Mechanical hypersensitivity following
SNI is represented as a change in mechanical
threshold over baseline in percentage in (C) and
as an integral of the entire von Frey stimulus
intensity-response frequency curve for von Frey
hair forces ranging from 0.07 to 1 g over time after
SNI in (D) (n = 7–8; *p < 0.05 relative to baseline;
n.s., nonsignificant; yp < 0.05 relative to mCherry).
All data are expressed as mean ± SEM. See also
Figure S5.
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Nuclear Calcium Signaling in Pain(Gao and Ji, 2010), were observed to be downregulated in spinal
dorsal horn samples of inflamed mice after CFA using QRT-PCR
(Figure 6A). Conversely, we found that genes including egr1,
Ptgs2, and c-fos, which were upregulated in inflamed mice in
our profiling analyses (Figures 3E, 3F,and 5E), are downregu-
lated at 7 days after the induction of spared nerve injury (SNI),
a model of neuropathic pain (Figure 6B). In the SNI model of
neuropathic pain, mice injected with mCherry or CaMBP4
showed a similar drop in response threshold to von Frey stimuli
over basal values (calculated as a force eliciting a minimum of
40% response frequency to five applications of each von Frey
hair) (Figure 6C). When stimulus intensity-response frequency
analyses were compared for all von Frey forces tested by calcu-
lating the AUC, only a small, but statistically significant, decrease
in the extent of SNI-induced mechanical hypersensitivity was
observed in CaMBP4-injected mice compared to mCherry-
injected mice (Figure 6D), which can also be attributed to
ongoing inflammation at the nerve injury site. This indicates
differences in the requirement of nuclear calcium signaling in
spinal excitatory neurons in inflammatory and neuropathic pain
processes.
Bioinformatics Analysis of Genes and Pathways
in Spinal Pain Processing
We subjected 421 putative targets of nuclear calcium signaling
in spinal dorsal horn neurons in inflammatory pain that were
identified by the criteria used (Table S1) to further bio-
informatics analysis of putative molecular ontology, pathways,
and function using the bioCompendium database of theNeuron 77, 43–European Molecular Biology Laboratory
(http://biocompendium.embl.de).Thebest-
represented functional ontologies in our
group of regulated genes corresponded
to protein-binding activities, of which
about a quarter show binding to cytoskel-
etal elements. Among the genes encoding
receptor molecules, the largest fractionwas represented by GPCRs, followed by tyrosine kinase recep-
tors, cytokine receptors, glutamate receptors, GABA-A recep-
tors, and surprisingly, receptors of the immunoglobulin families.
Finally, about 4% of the nuclear calcium target genes in the
spinal dorsal horn were kinases, in particular protein tyrosine
and threonine/serine kinases, including members of the MAP
kinase and the calcium/calmodulin-dependent kinase family, as
well as the lipid kinase, di-acyl glycerol kinase.
In a second step, we performed a network analysis using the
MetaCore database (Ekins et al., 2007) on genes chosen from
profiling data. For example, a birds-eye view of the interactions
between all genes that are upregulated, is provided in Fig-
ure S4. Within these interactions, we found a number of genes
to be clustered in highly connected networks, which are indi-
cated by an arrow in Figure S4A, and are shown at a higher
magnification in Figure S4B. Transcription factors (TFs) such
as STAT-3 and STAT-1 (Figure S4B) were found to serve as
key nodal points in interaction maps of the nuclear calcium-
regulated gene pool, potentially implicating these TFs as key to
the cellular response to nuclear calcium signaling.
Identification of a Nuclear Calcium Target
and its Functional Validation as a Modulator
of Inflammatory Pain
Two distinct prediction algorithms for pathway analysis
(Ingenuity Systems and MetaCore; Ekins et al., 2007) indepen-
dently suggested ‘‘Immune response classical complement
pathway’’ as the most significantly altered pathway in the
spinal dorsal horn following peripheral inflammation. In profiling57, January 9, 2013 ª2013 Elsevier Inc. 51
Figure 7. Analysis of C1q, a Nuclear Calcium
Target, Its Relation to Spinal Microglia, and
Its Role in Dendritic Spine Remodelling in
Spinal and Hippocampal Neurons In Vitro
(A) Quantitative RT-PCR analysis of spinal
expression of C1q-c at 24 hr after hindpaw injec-
tion of CFA and at 6 days after SNI over basal state
in CaMBP4 or mCherry mice (n = 4 each).
(B and C) Spinal microglia identified via Iba1-
immunoreactivity in the spinal dorsal horns of
control mice, inflamed mice, and inflamed mice
treated with intrathecal C1q (100 ng) for 48 hr
(n = 3 mice per group).
(D and E) Typical examples (D) and quantitative
summary (E) of morphometric analysis of EGFP-
labeled synaptic spines on cultured, mature
spinal cord neurons following treatment with C1q
(100 ng) or vehicle over 24–96 hr or following
treatment with shRNA against C1q expression
or control RNA (scale bar, 50 mm in the upper
panels and 5 mm in the lower panels; at least n = 3
different culture preparations).
(F) Quantitative RT-PCR analysis of expression of
the C1qc subunit of the trimeric C1q complex
validating shRNA-mediated knockdown.
(G) Typical examples of spinal neuronal
morphology and spine density in spinal neurons
with AAV-mediated downregulation of C1q
expression compared to controls.
(H) Quantitative RT-PCR analysis of C1q-c
expression in uninfected hippocampal neurons
and in hippocampal neurons infected with rAAVs
expressing the indicated proteins (n = 4; *p < 0.05
compared to uninfected).
(I and J) Typical examples (I) and quantitative
summary (J) of morphometric analysis of EGFP-
labeled synaptic spines on hippocampal neurons
at 10 days or 16 days in vitro (DIV) (scale bar =
20 mm in the upper panels and 5 mm in the
lower ones) upon treatment with C1q (100 ng)
or vehicle over 24–96 hr or following viral ex-
pression of C1q-c shRNA or scrambled RNA
(*p < 0.05 as compared to corresponding control;
n = more than 600 spines counted, 12 neurons
per condition, three independent culture prepara-
tions).
All data are expressed as mean ± SEM. See also
Figures S6 and S7.
Neuron
Nuclear Calcium Signaling in Painanalysis, we found that mCherry-expressing mice, but not
CaMBP4-expressing mice, showed a significant downregu-
lation of genes encoding the complement proteins, such as
the initiator of the complement cascade C1q (including all
three members of the active complex) as well as C1, C3a,
C4a, C4b, and C3 convertase in the spinal cord after paw
inflammation. QRT-PCR analysis for one member of the
trimeric complex, C1q-c in CaMBP4-expressing mice, not
only confirmed that nuclear calcium signaling in spinal neurons
mediates nociception-induced downregulation of C1q, but
also indicated that it suppresses a pathway involved in sus-
taining basal C1q expression levels in the spinal neurons
(Figure 7A).52 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.An upregulation of complement proteins including C1q, has
been observed in spinal microglia after nerve injury, which is
consistent with our observation of C1q-c upregulation in the
spinal cord of neuropathic mice (Figure 7A), and has been asso-
ciated with the activation and proliferation of microglia in the
spinal cord (Griffin et al., 2007). This mechanism did not appear
likely in the our experimental paradigms, given that we observe
a downregulation of C1q after paw inflammation and that
molecular perturbations applied in this study were restricted
to neurons (above; During et al., 2003) (Figures 1 and S1).
Furthermore, consistent with previous reports (e.g., Lin et al.,
2007), we did not observe an overt spinal microglial activa-
tion as assayed by Iba1 immunoreactivity in inflamed mice
Neuron
Nuclear Calcium Signaling in Pain(Figures 7B and S5A), in contrast to neuropathic mice (Fig-
ure S5C). Furthermore, intrathecal application of C1q to mice
with paw inflammation did not induce microglial proliferation or
recruitment (Figures 7C and S5B).
Inspired by recent studies implicating C1q-like proteins, which
resemble C1q in structure and functional motifs, in synaptic
morphogenesis during brain development (Chu et al., 2010;
Stevens et al., 2007), we investigated whether C1q canmodulate
synaptic contacts on mature excitatory neurons of the spinal
cord. Dissociated neonatal mouse spinal cord cultures matured
over 4 weeks in vitro were infected with an rAAV-CaMKII-EGFP
construct enabling visualization of the dendritic trees and
synaptic spines in virus-targeted excitatory neurons. A signifi-
cant reduction in the density of EGFP-labeled dendritic synaptic
spines was observed upon a single application of C1q, but not
vehicle alone, to mature cultures within 24 hr, and was even
more pronounced at 96 hr (typical examples in Figure 7D; a quan-
titative analysis in Figure 7E). C1q application did not evoke
signs of nuclear damage or cell death in neurons (data not
shown). Spinal expression of rAAVs expressing shRNAs against
C1q-c (validation in neurons via QRT-PCR is shown in Figure 7F)
led to a small, but significant, increase in spine number on
dendrites of cultured spinal neurons (Figure 7G).
Similar to the results obtained with spinal cord neurons,
expression of CaMBP4 in hippocampal neurons led to an
increase in C1q-c expression, confirming C1q-c as a nuclear
calcium-regulated gene (Figure 7H). Application of recombinant
C1q markedly reduced spine density on hippocampal neurons
(Figure 7I, quantification in Figure 7J). However, in contrast to
spinal neurons, we did not detect a significant effect of the
knockdown of C1q-c via shRNA on the spine density of hippo-
campal neurons (Figure 7J).
We next investigated the role of C1q as a possible modulator
of synaptic spine density in vivo by performing Golgi staining on
spinal cords derived frommice 24 hr after intraplantar paw injec-
tion of CFA or PBS (Figure 8A). Because the very superficial
dorsal horn neurons displayed less sensitivity to impregnation,
we restricted our analysis to lamina II neurons and mostly to
large pyramidal lamina V neurons. These showed a marked
increase in spine density on primary and secondary dendrites
in inflamed mice as compared to control mice (examples in
Figure 8B, higher magnification in Figure 8C, and quantification
in Figure 8D). Mice injected spinally with rAAV-C1q-c-shRNA-
GFP showed an increase in spine density on spinal neurons as
compared to rAAV-scrambled-shRNA-GFP-injected mice (Fig-
ures 8C and 8F). In contrast, following intrathecal application
of recombinant C1q in inflamed mice, CFA-associated increase
in spine density was significantly reduced (Figures 8C and 8D).
Similarly, following stereotaxic in vivo injection of C1q in the
hippocampus of adult mice, a significant reduction in spine den-
sity of pyramidal neuronsofCA1 regionwasobserved (Figure 8E).
Finally, nuclear calcium-evoked spinal C1q downregulation
was simulated by injection of rAAV-C1q-c-shRNA-GFP (using
rAAV-scrambled-RNA as a control) into the spinal dorsal horn.
Whereas basal mechanical sensitivity was largely unaltered
upon spinal C1q knockdown, the extent of inflammatory
mechanical hypersensitivity in these mice was significantly
increased when compared to mice expressing scrambledcontrol RNA (Figures 8G, S7A, and S7B). Conversely, when we
intrathecally applied recombinant trimeric C1q, significant atten-
uation of CFA-induced mechanical and thermal hypersensitivity
was observed (Figures 8H, 8I, S7C, and S7D; p < 0.05, ANOVA)
without any change in basal thermal and mechanical sensitivity
in the absence of inflammation (Figures S8A–S8D). Taken
together with themorphological data, these experiments provide
evidence for a nuclear calcium target gene in the modulation
of inflammation-associated pain hypersensitivity as well as
structural plasticity.
DISCUSSION
The interplay among synaptic receptors, cytoplasmic effectors,
and the nucleus plays a critical role in linkingmembrane depolar-
ization to gene transcription. Here, we show that high-threshold,
persistent nociceptive input leads to calcium entry into the
nuclei of spinal dorsal horn neurons, which exhibit a specific
transcriptional response, and that this stimulation drives struc-
tural remodelling in spinal excitatory neurons and functional
changes leading to chronic inflammatory hypersensitivity.
We observed that progressively augmenting recruitment of
A-delta afferents and C-type nociceptors as well as stimulating
nociceptors with increasing frequencies led to progressively
larger amplitude activity evoked nuclear calcium signals, sug-
gesting that nuclear calcium integrates spinal neuron input
from persistent activation of nociceptors after injury. Interest-
ingly, using constant stimulation parameters in naive or CFA-
inflamed mice, we found no detectable differences in the
characteristics of evoked nuclear calcium signals, consistent
with the concept that nuclear calcium transients are upstream,
not downstream, of activity-induced plasticity. These data
are consistent with the observed specific role for CaMBP4 in
markedly attenuating inflammatory hypersensitivity triggered
repetitive activation of nociceptors without affecting basal and
acute nociceptive responses evoked by an acute activation of
nociceptors. These findings, taken together with the results
of experiments addressing the temporal profile of the impact of
blockade nuclear calcium signaling on nociceptive hypersensi-
tivity, indicate that a genomic program governed by nuclear
calcium signaling in spinal neurons plays a major role in the
induction of long-lasting nociceptive hypersensitivity following
persistent nociceptive activity, but not in its maintenance.
Nociceptive activity induced phosphorylation of CREB has
been reported in models of inflammatory and neuropathic pain
(Ji and Rupp, 1997). CaMKII activity as well as protein kinases
PKA, PKC, and ERK1/2 have been implicated in CREB phos-
phorylation in spinal nociceptive neurons (Kawasaki et al.,
2004). We observed that blocking nuclear calcium signaling in
spinal excitatory neurons blocked nociceptive activity driven
phosphorylation of CREB although ERK1/2 were activated nor-
mally, indicating that other synapse-to-nucleus messengers
are not sufficient for activating CREB in spinal neurons in the
absence of nuclear calcium signaling. These findings, together
with the observation that inflammatory hypersensitivity was
attenuated by inhibiting CaMKIV activity, indicate that nuclear
calcium-CaMKIV-CREB/CBP signaling is the primary mediator
of long-term nociceptive sensitization.Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc. 53
Figure 8. Spine Remodelling in Spine Dorsal
Horn Neurons following Peripheral Inflam-
mation In Vivo via the Nuclear Calcium
Target, C1q, and its Role in Inflammatory
Pain Hypersensitivity
(A) Typical example of Golgi staining on spinal
dorsal horn slices with neurons labeled across
lamina II–V. Scale bar, 200 mm.
(B) Typical examples of labeled neurons in mice
injected intraplantar with PBS or CFA (24 hr post-
injection). Scale bar, 20 mm.
(C) High-magnification views of microscopic
images of labeled dendrites with synaptic spines in
mice with intraplantar injection of PBS or CFA
(24 hr) and treated intrathecally with vehicle or C1q
(100 ng). Right-hand panels represent images
from mice with rAAV-mediated expression of C1q
shRNA or scrambled RNA in spinal dorsal horn
neurons in vivo. Scale bar, 10 mm.
(D and E) Quantitative summary of synaptic spine
density in spinal dorsal horn neurons (D) or in
hippocampal neurons (E) in vivo following intra-
thecal injection (D) or direct intrahippocampal
injection (E) of C1q (100 ng) (three or four animals
per condition, 20–30 neurons, 500–700 spines
counted analyzed spinal neurons; two animals per
condition, 14 neurons, more than 600 spines
analyzed for hippocampal neurons).
(F) Quantitative summary of synaptic spine density
in spinal dorsal horn neurons in mice with rAAV-
mediated expression of C1q-c shRNA or scram-
bled RNA (two animals, 20 neurons per condition,
300–500 spines counted).
(G) CFA-induced mechanical hypersensitivity in
mice injected with rAAV-C1qc-shRNA or rAAV-
scrambled RNA at 24 hr (G) (n = 3–4 per group).
(H and I) CFA-induced mechanical hypersensitivity
(H) or thermal hyperalgesia (I) in mice following
intrathecal administration of recombinant C1q
(100 ng) or vehicle three times over a 24 hr period
post-CFA (H) (n = 6 each group).
In (D), (G), (H), and (I): *p < 0.05 compared to
baseline values within the same group; yp < 0.05
compared to the corresponding control group. In
(E) and (F): *p < 0.05 between the two groups
(ANOVA followed by post hoc Dunnett’s test). In
all panels, ANOVA followed by post hoc Dunnett’s
test. All data are expressed as mean ± SEM.
See also Figures S7 and S8.
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Nuclear Calcium Signaling in PainWhole-genome expression array analysis indicated that the
transcriptional program controlled by nuclear calcium in spinal
nociceptive neurons spans a wide range of genes, including
key modulators of nociceptive processing and neuronal excita-
tion. These include several ion channels such as the beta4
subunits of voltage-dependent calcium channels, GABA-A
channel subunits, and the alpha2/delta3 variant of voltage-
dependent calcium channels, which was recently identified as
an evolutionarily conserved pain gene regulating noxious heat
pain from Drosophila to humans (Neely et al., 2010), among
others. Interestingly, spinal nuclear calcium targets spanned
several key components of the cellular machinery involved in
promoting AMPA receptor-mediated transmission at spinal54 Neuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc.synapses (e.g., CaMKIIa, GRIP1), which play a key role in poten-
tiating synapses, unsilencing synapses, and the development
of nociceptive hypersensitivity in vivo (Li et al., 1999; Fang
et al., 2002). Several of the spinal nuclear calcium-regulated
genes are directly or indirectly involved in spinal long-term
potentiation (LTP) mechanisms (Sandku¨hler, 2009), consistent
with our observation that LTP paradigms yield the highest
magnitudes of nuclear calcium transients in spinal neurons.
Nuclear calcium signaling is involved in the transition from early
LTP to late LTP in hippocampal pyramidal neurons (Bengtson
et al., 2010), indicating a scope for nuclear calcium signaling in
facilitation and amplification of peripheral nociceptive infor-
mation passing through the spinal cord on its way to the brain.
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relevant GPCRs, GASP1, a protein that critically regulates traf-
ficking and lysosomal sorting of GPCRs and thereby mediates
drug tolerance to GPCR ligands (Tappe-Theodor et al., 2007),
as well as diverse chemokines, diverse cathepsins, and matrix
metalloproteases that have been implicated in synaptic modula-
tion and neuron-glia communication (Kawasaki et al., 2008, Gao
and Ji, 2010).
An important advantage of the combined approach of cell-
specific molecular perturbations, genome-wide profiling, and
detailed bioinformatics analyses employed here was that it
opened possibilities for discovering mediators of plasticity
governed by nuclear calcium, which could thereby offer unprec-
edented insights into mechanisms of persistent pain. Among the
mediators found in silico,we focusedon thecomplement system,
which we identified as a prominently modulated pathway in
neurons of inflamed mice, different from its previously reported
activation in spinal glia of neuropathic mice (Griffin et al., 2007).
As described in detail in Results, our findings suggest a differen-
tial and reciprocal modulation of the complement system in
microglia and neurons in neuropathic and inflammatory pain
states, respectively, and we report that the pain-modulatory
role for C1q in inflammatory states described here is associated
with synapse elimination in spinal neurons in response to afferent
activity, rather than microglial modulation. Because modulation
of C1q expression by CaMBP4 as well as shRNAs was restricted
to spinal excitatory neurons, which thereupon showed reciprocal
changes in spine density, we deduce that spinal excitatory
neuronal circuits constitute both the locus of C1q regulation
as well as its action, either in an autocrine or paracrine manner.
Interestingly, our analyses on hippocampal neurons indicate
that C1q is a common target of nuclear calcium signaling across
neuronal types, and taken together with data on the role of
C1q-like proteins in developmental synapse pruning in the brain
(Chu et al., 2010; Stevens et al., 2007), appears to function as
global regulator of not only developmental spine morphogenesis,
but also activity dependent remodelling. Indeed, bybidirectionally
alteringC1q expression in spinal neurons and combining thiswith
morphometric and behavioral analyses, we observed very in-
triguing and close connections between nociceptive activity,
C1q expression levels, the density of synaptic spines on spinal
neurons in vivo, and the magnitude of inflammatory hypersensi-
tivity. These findings suggest that inflammatory pain involves a
concertedand tightly regulatedunfoldingof processesunderlying
structural remodelling and functional plasticity, and that nuclear
calcium signaling plays a key role in these mechanisms.
In summary, this study places nuclear calcium signaling as
a key synapse-to-nucleusmessenger system in spinal excitatory
neurons. Moreover, it provides evidence that a nuclear calcium-
driven genomic program shapes activity dependent functional
plasticity as well as structural remodelling in spinal circuits,
thereby amplifying nociceptive sensitivity.EXPERIMENTAL PROCEDURES
Virus Production and In Vivo Injection
An rAAV vector with an AAV1/AAV2 chimeric backbone containing a 1.3 kbp
fragment of the mouse CaMKIIa promoter was used to express diverseproteins. Viral particles were produced, purified, and injected intrahippocam-
pally as described previously (Zhang et al., 2009, Mauceri et al., 2011). Spinal
cord injections of virions (2–5 3 109 particles/ml, 500 nl of a 2:1 mixture with
20% mannitol) in C57BL/6J adult mice were performed as described previ-
ously (Tappe-Theodor et al., 2007) at least 3 weeks after surgery and prior to
behavioral, morphological, or imaging experiments. Please see Supplemental
Experimental Procedures for details.
Transgenic Indicator Mice
Mice expressing EGFP under the control of the promoter of the glycine
transporter 2 (GlyT2) gene were used for identifying glycinergic neurons
(a generous gift from H.U. Zeilhofer, University of Zu¨rich). Mice expressing
EGFP under control of GAD 67 were used for identifying GABAergic neurons
(a generous gift from H. Monyer, University of Heidelberg).
Calcium Imaging
Lumbar spinal slices with attached dorsal roots were derived from virally in-
jected mice as described in detail previously (Luo et al., 2008). Dorsal roots
were stimulated with 1 s trains (1–100 Hz) of 0.2–3.0 mA square electrical
pulses lasting 0.2 ms, and Ca2+ responses elicited were imaged as described
in detail previously (Bengtson et al., 2010). See Supplemental Experimental
Procedures for further details.
Behavioral Testing of Nociception and Pathological Nociceptive
Sensitivity
All animal use procedures were in accordance with ethical guidelines imposed
by the local governing body (Regierungspra¨sidium Karlsruhe, Germany) and
involved mice aged 8–16 weeks and matched for gender and age. Inflam-
mation of the paw or knees (arthritis) was induced by subcutaneous plantar
injection of 20 ml Complete Freund’s Adjuvant (CFA, Sigma) or 4% Kaolin
(Sigma, K7375) with 2% Carrageenan Lambda (Sigma, C-3889) under isoflur-
ane anesthesia subcutaneously, as described previously (Gangadharan et al.,
2011). The SNI model of neuropathic pain was employed ligating and severing
common peroneal and tibial branches of the left sciatic nerve. Behavioral
testing was carried out in habituated mice by an observer blinded to the iden-
tity of the groups.Mechanical sensitivity was determined upon pawwithdrawal
to either application of graded force via a dynamic aesthesiometer (Ugo Basile)
or to manual application of graded von Frey hairs (0.008–4 g) to the plantar
surface (Gangadharan et al., 2011). To determine thermal sensitivity, paw
withdrawal latency to a ramp of infrared heat was measured using a plantar
test apparatus (Ugo Basile). Formalin (1%, 20 ml) or capsaicin (0.03%, 20 ml)
was injected into the plantar surface of the hindpaw, and the duration of
nocifensive behaviors (lifting, licking, or flinching) was measured over 60 min
or 5 min, respectively, postinjection (Gangadharan et al., 2011). Additional
details are given in the Supplemental Experimental Procedures.
Antibodies Used for Western Blotting or Immunohistochemistry
The following antibodies were used in dilutions in 5% normal horse serum in
PBS for immunohistochemistry: monoclonal rabbit anti-pCREB und anti-
pERK (Cell Signaling) 1:100; monoclonal mouse anti-NeuN, 1:500 (Millipore);
monoclonal rabbit anti-GFAP, 1:500 (DAKO); polyclonal goat anti-Iba-1,
1:150 (Abcam); rabbit anti-Flag-M2 AB, 1:1,000 (Sigma); appropriate FITC-
conjugated secondary antibodies; anti-Fos antibody (rabbit anti-c-Fos Ab-5,
1:20,000, Merck) followed by biotinylated secondary anti-rabbit antibody
(1:200). Rabbit anti-P-CREB, anti-P-ERK1/2, anti-CREB, and anti-ERK1/2
(all from Cell Signaling Inc.) antibodies were used for western blotting at
1:1,000 in 5% BSA in TBS and Tween 20 overnight followed by anti-rabbit
HRP-conjugated antibody (1:2,000). See Supplemental Experimental Proce-
dures for further details.
Neuronal Cultures and Analysis of Spine Density
Hippocampal neurons from newborn C57BL/6J mice were cultured and trans-
fected with a plasmid encoding hrGFP on DIV8 using Lipofectamine 2000 as
described (Mauceri et al., 2011). Spinal cord cultures derived from mouse
embryos at embryonic day 16 were infected with rAAV-CaMKIIa-EGFP virions
at P7, fixed 4 weeks later, and examined with a laser-scanning confocal
microscope (Leica SP2 AOBS) using a 1003 objective (Leica). To analyzeNeuron 77, 43–57, January 9, 2013 ª2013 Elsevier Inc. 55
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Nuclear Calcium Signaling in Paindendritic spines in vivo, Golgi-Cox staining was performed using an FD
Rapid GolgiStain Kit (FD Neurotechnologies, Ellicott, MD, USA) as described
in detail in (Mauceri et al., 2011). See Supplemental Experimental Procedures
for more detail.
Quantitative RT-PCR
Quantitative RT-PCR was performed using TaqMan Universal PCR Master
Mix with a sequence detection system model 7300 Real Time PCR System
(Applied Biosystems, Foster City, CA, USA) with FAM dye-labeled TaqMan
MGB probes. See Supplemental Experimental Procedures for further details.
Statistics
All data are expressed as mean ± SEM. In behavioral, morphological, and
RT-PCR analysis, two-tailed unpaired Student’s t test or one-way ANOVA
with post hoc Dunnett’s or Fisher’s tests were used, as were t tests with
Benjamini-Hochberg correction for multiple comparisons. Differences with
p < 0.05 were considered to be significant.
Gene Profiling and Bioinformatics Analysis
cDNA samples for gene profiling analysis were prepared as described in
(Zhang et al., 2009) and analyzed as described under Supplemental Experi-
mental Procedures in detail. While representing genes regulated by CFA
inflammation over the naive state in mCherry-injected mice (i.e., controls), a
cutoff of 1.40 was applied for upregulated genes and a cutoff of 0.70 was
applied for downregulated genes. In order to assess how CFA-induced upre-
gulation or downregulation of genes was affected by interfering with nuclear
calcium signaling in spinal neurons, fold regulation (i.e., CFA over naive) was
compared between mCherry-injected mice and CaMBP4-injected mice. The
percent change in downregulation or upregulation was calculated for all genes
for which CaMBP4 fold-changes were %0.70 or R1.40 using the following
formula: 100% 3 [(CaMBP4  1)  (mCherry  1)] / (mCherry  1). For genes
for which CaMBP4 fold-changes were >0.70 or <1.40, the percent change in
downregulation or upregulation was set at 100%.
Gene Ontology analysis was performed on regulated genes using a Perl
program map2slim from go-perl (http://search.cpan.org/cmungall/go-perl/
go-perl.pod) as described in detail in the Supplemental Experimental Proce-
dures. Network analysis and visualization and pathway analysis were per-
formed using MetaCore (http://www.genego.com; Ekins et al., 2007) as
described in detail in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
Complete profiling data have been uploaded in the public domain with the
accession number E-MTAB-1416.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2012.10.037.
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